with an obvious commitment to quality is likely to reflect difficulty of extending a linear model into an environment which is complex and adaptive. 3 As this healthcare environment is also knowledge-based and creates vast amounts of data doctors with an interest in quality assurance should familiarize themselves with data mining for patterns of care as an aid to discovering better processes 4 and meeting inequalities in care. 5
Research governance approval delays studies
In the May 2009 edition of JRSM your headline article was 'Research governance delays for a non-interventional study' a sentiment which many researchers may share. 1 The authors put the reasons for delay clearly in the arms of research and development departments (RDD) where significant variation in processes leads to variation in delay. While we do not defend the over-bureaucratic system for research approval in the UK our findings suggest that the reason for delay must be shared among those involved in the study. In 2006 we published an article which examined the delays in a similar multicentre observational study which involved 178 sites across the UK, of which 159 were hospital trusts. 2 We examined the reason for delay at all sites taking more than 60 days for approval (i.e. more than the legally specified time currently required for ethics committee review). 3 We found that the mean approval time was 82 days with a range of 0-259 days, thus supporting the wide variation identified by Mallick and O'Callaghan. In our analysis more than half the hospital sites took longer than 60 days (n=86, mean 126 days) to obtain local approval. We examined the source of the delay and found that of those cases taking more than 60 days, 25 (29%) were delayed at the RDD while 22 (26%) were delayed while awaiting investigators to respond to queries and 11 (13%) delayed at the trust level awaiting sign off. The remaining 28 had mixed reasons for delay beyond 60 days.
We therefore support the call for an improved approval system but would suggest that all parties involved in the approval process must be prepared to support change and act in a timely manner.
Sir Vidia's 'racism'
I was surprised to read in the JRSM, of all places, a gratuitous reference to VS Naipaul's 'racism' from Jim Thornton, 1 who has just read a new biography of the great writer. 2 The biographer, Patrick French, indeed pulls no punches (like Naipaul himself), yet he does not call his subject a racist or show him to be one. If the charge is levelled with tiresome regularity by certain PC critics, this is because Naipaul has not fallen for the fallacy of 'the superior virtue of the oppressed', as Bertrand Russell, not a racist either, once called it. To read Naipaul's works with both eyes open is to understand that they are one long and masterful plea for human dignity and freedom. His knighthood and Nobel Prize are an honour, not just to him, but to Britain and the world.
Maynard made me laugh
Alan Maynard's statement that the Irish have moved to offer their population 'free' prescriptions 1 made me laugh. Alas, he couldn't be more wrong. Six months ago, the financial shambles, brought about by banksters and weak regulators, caused the Irish government to remove free medical attention, including free prescriptions, from those lucky enough to have qualified for a 'medical card', but unfortunate to have a weekly income over V700. However, no-one has to pay more than V100 for medications in any month.
It's impossible to say how long this situation will last. Probably for a long time, since we're expecting even more swingeing cuts in social services in the coming months.
